COURTNEY LENNON: Open Payments
NPI 1740735919 · HOLLYWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,812 in 88 payments from 24 companies in 2025. Trend: 2023 $1,710 · 2024 $1,822 · 2025 $1,812
Food & beverage: $1,812
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $213 |
| ABBVIE INC. | 15 | $208 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $193 |
| Gilead Sciences, Inc. | 6 | $155 |
| Amgen Inc. | 10 | $140 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $130 |
| Lilly USA, LLC | 5 | $90 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $75 |
| Verity Pharmaceuticals Inc. | 3 | $71 |
Products named: CAPLYTA, AIRSUPRA, VRAYLAR, OTEZLA, JARDIANCE, Kerendia, TRINTELLIX, MOUNJARO.
Industry payments across FL — which companies pay providers there.
